Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.
Allin, Kristine H
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study. [electronic resource] - Breast cancer research : BCR Jun 2011 - R55 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1465-542X
10.1186/bcr2891 doi
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor--blood
Breast Neoplasms--diagnosis
C-Reactive Protein--metabolism
Cohort Studies
Disease-Free Survival
Female
Follow-Up Studies
Humans
Middle Aged
Neoplasm Recurrence, Local
Prognosis
Risk Factors
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study. [electronic resource] - Breast cancer research : BCR Jun 2011 - R55 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1465-542X
10.1186/bcr2891 doi
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor--blood
Breast Neoplasms--diagnosis
C-Reactive Protein--metabolism
Cohort Studies
Disease-Free Survival
Female
Follow-Up Studies
Humans
Middle Aged
Neoplasm Recurrence, Local
Prognosis
Risk Factors